# Evaluating Treatment of ADHD in Children with Down Syndrome

> **NCT04219280** · PHASE4 · RECRUITING · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 100 (estimated)

## Conditions studied

- Down Syndrome
- ADHD

## Interventions

- **DRUG:** Quillivant XR
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04219280
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-10-02
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-09-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-01-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04219280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04219280, "Evaluating Treatment of ADHD in Children with Down Syndrome". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04219280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*